AMTM vs DXCM · rev $14.39B vs P/E 63, rev $2.50B
Amentum Holdings Inc. (AMTM) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Amentum Holdings Inc. (AMTM) is a specialty business services company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported AMTM revenue for 2025-10-03 was $14.39B. Net income was $66.0M. Revenue was up 71.6% from 2024-09-27 to 2025-10-03. AMTM currently screens at market cap $4.87B.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
AMTM currently screens at market cap $4.87B. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the AMTM and DXCM stock pages for the full models.
Not investment advice.